294.1 ð é«åžçç
294.1.0.1 ð äžé éé»
294.1.0.1.1 Athletic Heart Syndrome
294.1.0.1.1.1 Physiologic Adaptations to Training
- Endurance (running, cycling, swimming): predominantly volume overload â eccentric LVH + LV dilation + larger SV
- Strength / power (weightlifting): predominantly pressure overload â concentric LVH
- Combined (rowing, cycling): mixed
294.1.0.1.1.2 Findings (Adapted Heart)
- LVH (concentric or eccentric)
- LV dilation in endurance athletes (LVEDD up to 70 mm)
- RV dilation in endurance athletes
- Increased SV, lower resting HR
- Bradycardia at rest (HR 40-50 common)
- First-degree AV block (PR > 200 ms)
- Wenckebach (Mobitz I) in some
- Early repolarization
- Voltage criteria for LVH on ECG without clinical significance
294.1.0.1.2 Sudden Cardiac Death (SCD) in Athletes
294.1.0.1.2.1 Epidemiology
- Rare but devastating
- Incidence: 1 per 50,000-200,000 athlete-years
- Higher in: African American athletes, basketball, football, soccer
- Male > female (5-10:1)
294.1.0.1.2.2 Causes by Age
Young (< 35 yo): 1. Hypertrophic cardiomyopathy (HCM) â #1 in USA 2. Anomalous coronary artery origin (#1 in Italy autopsy data; LAD from R sinus or RCA from L sinus) 3. ARVC (Arrhythmogenic RV cardiomyopathy) 4. Long QT syndrome (LQTS) 5. CPVT (Catecholaminergic polymorphic VT) 6. Brugada syndrome 7. WPW + AF â VF 8. Myocarditis (viral, COVID-19) 9. Marfan with aortic dissection 10. Commotio cordis (blunt chest impact during vulnerable T wave period) 11. Idiopathic VF 12. Mitral valve prolapse + arrhythmic (rare) 13. CAD (increasingly recognized in some teens with extreme RF)
Older (> 35 yo): 1. Coronary artery disease (#1 by far) 2. Cardiomyopathies 3. Valvular heart disease
294.1.0.1.2.3 Pre-Participation Screening (PPS)
Components: - History: chest pain, dyspnea, syncope, palpitations, family hx of SCD < 50, family hx of inherited heart conditions - Physical examination: BP, murmurs, Marfan features, peripheral pulses - ECG (controversial in US): adds sensitivity
Different Approaches: - Italian model (since 1982): mandatory ECG + history + physical - AHA / US: history + physical; ECG selectively - ESC / IOC: ECG recommended - European trend toward ECG inclusion
294.1.0.1.3 ECG Interpretation in Athletes (Seattle / International Criteria)
294.1.0.1.3.1 âNormalâ Variants in Athletes
- Sinus bradycardia
- Sinus arrhythmia
- First-degree AV block
- Wenckebach (Mobitz I)
- Right bundle branch block (incomplete or complete with normal QRS in some)
- Voltage criteria for LVH alone
- Early repolarization
- T-wave inversion in V1-V3 (in some young black athletes)
294.1.0.1.3.2 Abnormal in Athletes â Investigate
- T-wave inversion in lateral or inferolateral leads (NOT physiologic)
- Pathologic Q waves
- ST depression
- Complete LBBB
- Mobitz II or higher-degree AV block
- VPCs > 2 per 10-second strip
- Long QT (corrected > 460 men, > 470 women, > 480 children)
- Brugada pattern
- WPW
- Epsilon waves (ARVC)
294.1.0.1.4 Specific Conditions
294.1.0.1.4.1 Hypertrophic Cardiomyopathy (HCM)
- See Ch270 + 268
- Sarcomere mutations (MYH7, MYBPC3, TNNT2)
- LV wall thickness ⥠15 mm in adults
- Family screening
- Risk stratification: family hx of SCD, syncope, NSVT, â wall thickness ⥠30 mm, abnormal BP exercise, LGE
Athletes with HCM: - 2024 ACC/AHA + LIVE-HCM (2023): moderate-intensity exercise safe (vs older blanket prohibition) - ICD does NOT automatically disqualify - Multidisciplinary assessment - Individual + competitive decisions
294.1.0.1.4.2 Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
- Desmosomal mutations (PKP2, DSP, DSG2)
- RV fibrofatty replacement
- Triangle of dysplasia
- VT with LBBB morphology
- Epsilon waves on ECG
- Often presents in athletes with VT during exercise
- ICD + restrict competitive sports
294.1.0.1.4.3 Long QT Syndrome (LQTS)
- LQT1: KCNQ1 â exercise-induced (swimming)
- LQT2: KCNH2 â startle, postpartum
- LQT3: SCN5A â sleep
- Treatment: β-blocker (nadolol, propranolol), ICD if recurrent, lifestyle (avoid QT-prolonging meds)
- LQT1 + swimming avoidance
294.1.0.1.5 COVID-19 + Athletes
294.1.0.1.5.1 Risk
- Acute myocarditis
- Post-acute sequelae (PASC, long COVID)
- Risk of arrhythmia, SCD during recovery
294.1.0.1.5.2 Return to Play
- Mild COVID + asymptomatic: 3-7 days rest
- Moderate symptoms: 10-day rest + symptom resolution
- Cardiac symptoms / hospitalization: cardiology evaluation
- Suspected myocarditis: 3-6 month exercise restriction; CMR + serial follow-up
- Lake Louise CMR criteria + clinical assessment
294.1.0.2 𩺠åºé鿥
- Athletic heart: eccentric LVH (endurance) or concentric (strength); bradycardia, 1° AV block, voltage criteria LVH â all physiologic
- SCD young athletes: HCM (US), anomalous coronary (Italy), ARVC, LQT/Brugada, myocarditis
- SCD older athletes: CAD (#1)
- HCM athletes 2024: moderate exercise OK (LIVE-HCM); ICD â automatic disqualification
- Commotio cordis: blunt chest impact during T wave â VF â AED + CPR
- COVID-19 myocarditis: 3-6 mo exercise restriction; CMR + monitoring
- Pre-participation: history + physical; Italian model adds ECG (â SCD ~ 90%)